ATI RN
ATI Pharmacology Proctored Exam 2019 Questions
Question 1 of 5
A patient in an acute mental health facility is experiencing withdrawal from opioid use and has a new prescription for Clonidine. Which of the following actions should the nurse identify as the priority?
Correct Answer: D
Rationale: In this scenario, the priority action for the nurse is to obtain baseline vital signs. This is crucial for establishing a baseline assessment, especially for a patient undergoing opioid withdrawal and starting a new medication like Clonidine. Monitoring vital signs is essential for evaluating the patient's response to treatment and detecting any potential complications early on.
Question 2 of 5
A nurse is providing teaching to a client who has a new prescription for Warfarin. Which of the following statements by the client indicates a need for further teaching?
Correct Answer: C
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 3 of 5
A client is taking Spironolactone. Which of the following laboratory findings should the nurse monitor and report to the provider?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A client has a new prescription for Furosemide. What instruction should be included by the nurse during discharge?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
A client has been prescribed Aspirin for prevention of cardiovascular disease. Which of the following findings indicates the medication is effective?
Correct Answer: C
Rationale: The correct answer is C. A decrease in episodes of angina indicates that Aspirin is effectively preventing the formation of clots that could lead to cardiovascular events. Angina is chest pain or discomfort caused by reduced blood flow to the heart muscle, usually due to coronary artery disease. Aspirin works by inhibiting platelet aggregation, thereby reducing the risk of clot formation in the arteries. Improvement in angina symptoms suggests that the medication is successfully preventing clot-related complications in the cardiovascular system. Monitoring and recognizing a decrease in angina episodes can be a valuable indicator of the medication's efficacy in preventing cardiovascular events.